{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T01:18:59Z","timestamp":1783214339774,"version":"3.54.6"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018883","name":"Maurice Wilkins Centre for Molecular Biodiscovery","doi-asserted-by":"publisher","award":["3731156"],"award-info":[{"award-number":["3731156"]}],"id":[{"id":"10.13039\/501100018883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001513","name":"Cancer Society of New Zealand","doi-asserted-by":"publisher","award":["CSNZ2326"],"award-info":[{"award-number":["CSNZ2326"]}],"id":[{"id":"10.13039\/501100001513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.actbio.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:07:09Z","timestamp":1780556829000},"page":"525-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A cancer stem cell-directed nano-chemotherapy enhances anti-PD-L1 immunotherapy in breast cancer by inducing immunogenic cell death"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6105-995X","authenticated-orcid":false,"given":"Jingjing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7747-8225","authenticated-orcid":false,"given":"Kamel S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengxuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5300-1934","authenticated-orcid":false,"given":"Andrew","family":"N\u2024 Shelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-9211","authenticated-orcid":false,"given":"Stephen","family":"M\u2024F\u2024 Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7749-8922","authenticated-orcid":false,"given":"George","family":"Laking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3115-8244","authenticated-orcid":false,"given":"David","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9777-0674","authenticated-orcid":false,"given":"Zimei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.actbio.2026.06.007_bib0001","doi-asserted-by":"crossref","first-page":"153","DOI":"10.25122\/jml-2021-0108","article-title":"Triple-negative breast cancer: current treatment strategies and factors of negative prognosis","volume":"15","author":"Baranova","year":"2022","journal-title":"J. Med. Life"},{"issue":"2","key":"10.1016\/j.actbio.2026.06.007_bib0002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.canlet.2012.09.023","article-title":"Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells","volume":"328","author":"Qiu","year":"2013","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-025-02265-2","article-title":"Cancer stem cells and niches: challenges in immunotherapy resistance","volume":"24","author":"Pan","year":"2025","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.actbio.2026.06.007_bib0004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00262-004-0593-x","article-title":"Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy","volume":"54","author":"Blank","year":"2005","journal-title":"Cancer Immunol., Immunotherapy"},{"issue":"5","key":"10.1016\/j.actbio.2026.06.007_bib0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00262-017-1954-6","article-title":"PD-1 and PD-L1 antibodies in cancer: current status and future directions","volume":"66","author":"Balar","year":"2017","journal-title":"Cancer Immunol., Immunotherapy"},{"issue":"10","key":"10.1016\/j.actbio.2026.06.007_bib0006","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/cncr.31272","article-title":"Checkpoint inhibitors in triple-negative breast cancer (TNBC): where to go from here","volume":"124","author":"Kwa","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.actbio.2026.06.007_bib0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ctrv.2017.12.008","article-title":"Checkpoint inhibitors in breast cancer\u2013current status","volume":"63","author":"Polk","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.actbio.2026.06.007_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113906","article-title":"Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy","volume":"156","author":"Rouzbahani","year":"2022","journal-title":"Biomed. PharmacOther"},{"issue":"4","key":"10.1016\/j.actbio.2026.06.007_bib0009","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1412909","article-title":"Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes","volume":"7","author":"Gabrusiewicz","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.actbio.2026.06.007_bib0010","series-title":"Brain Tumor-Initiating Cells Export tenascin-C Associated With Exosomes to Suppress T cell Activity","author":"Mirzaei","year":"2018"},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0011","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13287-024-04061-z","article-title":"Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies","volume":"15","author":"Li","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.actbio.2026.06.007_bib0012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2024.03.010","article-title":"Efficient chemo-immunotherapy leveraging minimalist electrostatic complex nanoparticle as \u201cin situ\u201d vaccine integrated tumor ICD and immunoagonist","volume":"69","author":"Han","year":"2025","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202301005","article-title":"Enhancing cancer chemo-immunotherapy: innovative approaches for overcoming immunosuppression by functional nanomaterials","volume":"8","author":"Wang","year":"2024","journal-title":"Small. Methods"},{"key":"10.1016\/j.actbio.2026.06.007_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120791","article-title":"Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity","volume":"272","author":"Yang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.06.007_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","article-title":"Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer","volume":"341","author":"Qiu","year":"2022","journal-title":"J. Controlled Release"},{"issue":"8","key":"10.1016\/j.actbio.2026.06.007_bib0016","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell\u2013immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.actbio.2026.06.007_bib0017","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.4161\/cc.9.12.12050","article-title":"Transcriptional crosstalk between tgf\u03b2 and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes","volume":"9","author":"Fuxe","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.actbio.2026.06.007_bib0018","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1039\/D5TB00305A","article-title":"Transforming \u201ccold\u201d tumors into \u201chot\u201d ones via immunogenic cell death by bufadienolides for reverse immunosuppressive TME in HCC","volume":"13","author":"Qiao","year":"2025","journal-title":"J. Mater. Chem. B"},{"issue":"10","key":"10.1016\/j.actbio.2026.06.007_bib0019","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1158\/1078-0432.CCR-19-3545","article-title":"FDA approval summary: atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1","volume":"26","author":"Narayan","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543784.2019.1552255","article-title":"Atezolizumab for the treatment of triple-negative breast cancer","volume":"28","author":"Heimes","year":"2019","journal-title":"Expert. Opin. Investig. Drugs"},{"issue":"38","key":"10.1016\/j.actbio.2026.06.007_bib0021","doi-asserted-by":"crossref","first-page":"32509","DOI":"10.1021\/acsami.7b09331","article-title":"Construction and evaluation of a targeted hyaluronic acid nanoparticle\/photosensitizer complex for cancer photodynamic therapy","volume":"9","author":"Gao","year":"2017","journal-title":"ACS. Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2026.06.007_bib0022","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijbiomac.2022.09.245","article-title":"Chitosan coated pH\/redox-responsive hyaluronic acid micelles for enhanced tumor targeted co-delivery of doxorubicin and siPD-L1","volume":"222","author":"Song","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.actbio.2026.06.007_bib0023","article-title":"Activation of CD44-lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis","volume":"1867","author":"Manupati","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol. Basis Disease"},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0024","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/08982104.2024.2389969","article-title":"Effect of size and pH-sensitivity of liposomes on cellular uptake pathways and pharmacokinetics of encapsulated gemcitabine","volume":"35","author":"Tang","year":"2025","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.actbio.2026.06.007_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2019.05.018","article-title":"Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?","volume":"305","author":"Tang","year":"2019","journal-title":"J. Controlled Release"},{"issue":"3","key":"10.1016\/j.actbio.2026.06.007_bib0026","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/08982104.2024.2305866","article-title":"Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells","volume":"34","author":"Gao","year":"2024","journal-title":"J. Liposome Res."},{"issue":"6","key":"10.1016\/j.actbio.2026.06.007_bib0027","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s11095-022-03206-0","article-title":"Calcium enabled remote loading of a weak acid into pH-sensitive liposomes and augmented cytosolic delivery to cancer cells via the Proton sponge effect","volume":"39","author":"Yang","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2026.06.007_bib0028","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ab.2016.10.004","article-title":"Optimization of the formation of embedded multicellular spheroids of MCF-7 cells: how to reliably produce a biomimetic 3D model","volume":"515","author":"Zhang","year":"2016","journal-title":"Anal. Biochem."},{"issue":"7","key":"10.1016\/j.actbio.2026.06.007_bib0029","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12032-022-01670-7","article-title":"Tumor-associated macrophages of the M1\/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway","volume":"39","author":"Chen","year":"2022","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.actbio.2026.06.007_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2021.8196","article-title":"BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP\u20111 cells via the Rb\/E2F1 pathway in cervical carcinoma","volume":"46","author":"Liu","year":"2021","journal-title":"Oncol. Rep."},{"issue":"1\u20132","key":"10.1016\/j.actbio.2026.06.007_bib0031","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-3659(03)00231-1","article-title":"Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect","volume":"91","author":"Son","year":"2003","journal-title":"J. Controlled Release"},{"issue":"6","key":"10.1016\/j.actbio.2026.06.007_bib0032","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1039\/D2BM01432G","article-title":"Trojan horse\" nanoparticle-delivered cancer cell membrane vaccines to enhance cancer immunotherapy by overcoming immune-escape","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2026.06.007_bib0033","doi-asserted-by":"crossref","first-page":"127022","DOI":"10.1016\/j.ijpharm.2026.127022","article-title":"A pH-sensitive nanococktail enabled cancer stem cell elimination, deep tumour penetration, and tumour shrinkage","volume":"700","author":"Ahmed","year":"2026","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.actbio.2026.06.007_bib0034","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10549-012-2175-5","article-title":"Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion","volume":"135","author":"Zhang","year":"2012","journal-title":"Breast. Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.actbio.2026.06.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1446720","article-title":"Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes","volume":"7","author":"Huang","year":"2018","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.actbio.2026.06.007_bib0036","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nm.4118","article-title":"RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers","volume":"22","author":"Nolan","year":"2016","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.actbio.2026.06.007_bib0037","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2217\/nnm.11.141","article-title":"Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming","volume":"6","author":"Wang","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2026.06.007_bib0038","doi-asserted-by":"crossref","DOI":"10.4014\/jmb.2503.03002","article-title":"Bufalin suppresses triple-negative breast cancer stem cell growth by inhibiting the wnt\/\u03b2-catenin signaling pathway","volume":"35","author":"Park","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"issue":"9","key":"10.1016\/j.actbio.2026.06.007_bib0039","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hed.21315","article-title":"Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase","volume":"32","author":"Clay","year":"2010","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-12-24","article-title":"Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden","volume":"12","author":"Abubaker","year":"2013","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.actbio.2026.06.007_bib0041","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/vaccines12111294","article-title":"Multiparameter flow cytometric analysis of the conventional and monocyte-derived DC compartment in the Murine spleen","volume":"12","author":"Backer","year":"2024","journal-title":"Vaccines. (Basel)"},{"key":"10.1016\/j.actbio.2026.06.007_bib0042","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2015.12.006","article-title":"Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity","volume":"222","author":"Zhao","year":"2016","journal-title":"J. Controlled Release"},{"issue":"2","key":"10.1016\/j.actbio.2026.06.007_bib0043","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/nsr\/nwx062","article-title":"The acidic tumor microenvironment: a target for smart cancer nano-theranostics","volume":"5","author":"Feng","year":"2018","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.actbio.2026.06.007_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.151663","article-title":"Dual nanoparticle immunostimulant hydrogel for synergistic combating \u201cCold\u201d tumor","volume":"490","author":"Zhang","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2026.06.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202501341","article-title":"Targeting IGF1R overcomes armored and cold tumor microenvironment and boosts immune checkpoint blockade in triple-negative breast cancer","volume":"12","author":"Wan","year":"2025","journal-title":"Adv. Sci."},{"issue":"1\u20132","key":"10.1016\/j.actbio.2026.06.007_bib0046","article-title":"Liposomal delivery enhances immune activation by STING agonists for cancer immunotherapy","volume":"1","author":"Koshy","year":"2017","journal-title":"Adv. Biosyst."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0047","article-title":"Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine","volume":"6","author":"Chen","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"17","key":"10.1016\/j.actbio.2026.06.007_bib0048","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3390\/molecules30173634","article-title":"Bufalin suppresses colorectal cancer liver metastasis by inhibiting De Novo fatty acid synthesis via the PI3K\/AKT-mediated SREBP1\/FASN pathway","volume":"30","author":"Pang","year":"2025","journal-title":"Molecules."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0049","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1038\/s41467-021-24591-x","article-title":"Fc\u03b3R engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity","volume":"12","author":"Mysore","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2026.06.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122290","article-title":"Chemotherapy-induced nanovaccines implement immunogenicity equivalence for improving cancer chemoimmunotherapy","volume":"301","author":"Li","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.06.007_bib0051","article-title":"Preventing glioblastoma relapse by igniting innate immunity through mitochondrial stress in the surgical cavity","author":"Han","year":"2025","journal-title":"Adv. Mater."},{"issue":"30","key":"10.1016\/j.actbio.2026.06.007_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202402322","article-title":"A synergistic chemoimmunotherapy system leveraging PD-L1 blocking and bioorthogonal prodrug activation","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"issue":"16","key":"10.1016\/j.actbio.2026.06.007_bib0053","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2026.06.007_bib0054","article-title":"Influence of tumor immune infiltration on immune checkpoint inhibitor therapeutic efficacy: a computational retrospective study","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2026.06.007_bib0055","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/pharmaceutics15030915","article-title":"DOPE\/CHEMS-based EGFR-targeted immunoliposomes for docetaxel delivery: formulation development, physicochemical characterization and biological evaluation on prostate cancer cells","volume":"15","author":"Moreira","year":"2023","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.actbio.2026.06.007_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113354","article-title":"Bufalin inhibits tumorigenesis, stemness, and epithelial\u2013mesenchymal transition in colorectal cancer through a C-Kit\/slug signaling axis","volume":"23","author":"Ding","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2026.06.007_bib0057","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1159\/000485279","article-title":"Bufalin inhibits cellular proliferation and cancer stem cell-like phenotypes via upregulation of MiR-203 in glioma","volume":"44","author":"Liu","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.actbio.2026.06.007_bib0058","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21037\/sci.2019.06.07","article-title":"Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotype","volume":"6","author":"Herheliuk","year":"2019","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.actbio.2026.06.007_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122369","article-title":"Biomimetic Prussian blue nanocomplexes for chemo-photothermal treatment of triple-negative breast cancer by enhancing ICD","volume":"303","author":"Long","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.06.007_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122851","article-title":"Gamabufotalin loaded micro-nanocomposites for multimodal therapy of metastatic TNBC by efficiently inducing ICD","volume":"314","author":"Fan","year":"2025","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2026.06.007_bib0061","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/cancers14040976","article-title":"Dissecting tumor growth: the role of cancer stem cells in drug resistance and recurrence","volume":"14","author":"Aramini","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"3","key":"10.1016\/j.actbio.2026.06.007_bib0062","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/08982104.2024.2305866","article-title":"Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells","volume":"34","author":"Gao","year":"2024","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.actbio.2026.06.007_bib0063","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jconrel.2023.01.023","article-title":"Bio-fabricated nanodrugs with chemo-immunotherapy to inhibit glioma proliferation and recurrence","volume":"354","author":"Wang","year":"2023","journal-title":"J. Controlled Release"},{"issue":"5","key":"10.1016\/j.actbio.2026.06.007_bib0064","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.apsb.2019.09.006","article-title":"Epigenetic strategies synergize with PD-L1\/PD-1 targeted cancer immunotherapies to enhance antitumor responses","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.actbio.2026.06.007_bib0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12967-020-02421-w","article-title":"ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer","volume":"18","author":"Kyte","year":"2020","journal-title":"J. Transl. Med."},{"issue":"29","key":"10.1016\/j.actbio.2026.06.007_bib0066","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202107787","article-title":"Siglec15 Checkpoint blockade for simultaneous immunochemotherapy and osteolysis inhibition in lung adenocarcinoma spinal metastasis via a hollow nanoplatform","volume":"18","author":"Liang","year":"2022","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.actbio.2026.06.007_bib0067","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s11095-022-03206-0","article-title":"Calcium enabled remote loading of a weak acid into pH-sensitive liposomes and augmented cytosolic delivery to cancer cells via the Proton sponge effect","volume":"39","author":"Yang","year":"2022","journal-title":"Pharm. Res."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270612600365X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270612600365X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T01:03:16Z","timestamp":1783213396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S174270612600365X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":67,"alternative-id":["S174270612600365X"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.06.007","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cancer stem cell-directed nano-chemotherapy enhances anti-PD-L1 immunotherapy in breast cancer by inducing immunogenic cell death","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}